Jon L. Giacomin
2016
In 2016, Jon L. Giacomin earned a total compensation of $3.3M as Chief Executive Officer—Pharmaceutical Segment at Cardinal Health, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $602,314 |
|---|---|
| Option Awards | $701,196 |
| Salary | $542,623 |
| Stock Awards | $1,400,062 |
| Other | $27,770 |
| Total | $3,273,965 |
Giacomin received $1.4M in stock awards, accounting for 43% of the total pay in 2016.
Giacomin also received $602.3K in non-equity incentive plan, $701.2K in option awards, $542.6K in salary and $27.8K in other compensation.
Rankings
In 2016, Jon L. Giacomin's compensation ranked 2,875th out of 14,075 executives tracked by ExecPay. In other words, Giacomin earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,875 out of 14,075 | 80th |
Division Wholesale Trade | 70 out of 367 | 81st |
Major group Wholesale Trade-non-durable Goods | 34 out of 141 | 76th |
Industry group Drugs, Drug Proprietaries, And Druggists' Sundries | 16 out of 30 | 47th |
Industry Drugs, Drug Proprietaries, and Druggists' Sundries | 16 out of 30 | 47th |
Source: SEC filing on September 21, 2017.
Giacomin's colleagues
We found four more compensation records of executives who worked with Jon L. Giacomin at Cardinal Health in 2016.